Antibacterial Activity for Acne Treatment through Medicinal Plants Extracts: Novel Alternative Therapies for Acne
Acne vulgaris is a chronic skin infection affecting the majority of adults. There are several internal and external factors responsible for this infection. The present study emphasizes the screening and combinations of medicinal plants extracts against acne-causing bacteria and antibacterial activ...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Journal of Pure and Applied Microbiology
2019-06-01
|
Series: | Journal of Pure and Applied Microbiology |
Subjects: | |
Online Access: | https://microbiologyjournal.org/antibacterial-activity-for-acne-treatment-through-medicinal-plants-extracts-novel-alternative-therapies-for-acne/ |
Summary: | Acne vulgaris is a chronic skin infection affecting the majority of adults. There are several internal
and external factors responsible for this infection. The present study emphasizes the screening and
combinations of medicinal plants extracts against acne-causing bacteria and antibacterial activity of
these plant extracts. Antibacterial activities of three solvents extracts of Camellia sinensis, Azadirachta
indica, and Cassia acutifolia was carried out using disc diffusion method against Propionibacterium
acnes, Staphylococcus aureus, Staphylococcus epidermidis, Pseudomonas aeruginosa, Escherichia
coli and Bacillus subtilis. The results revealed that different plant extracts showed noticeable activity
against different test organisms. The acetone extract of combination A (C/A) showed the higher mean
of antibacterial susceptibility against six bacterial strain with synergistic effect by 20.33mm than other
combinations when combination A (C/A) was added. The antimicrobial susceptibility of combination
A (C/A) was higher than combination group at concentration of 10-2 with 95% confidence interval. The
present study concluded that the acetonic extract of C/A was the best antibacterial agent/candidate
to treat acne vulgaris disease. Further trials might confirm its best possible doses for prescription to
the dermatologists, physicians and clinicians in the field.
|
---|---|
ISSN: | 0973-7510 2581-690X |